Skip to main content
Quest Diagnostics

RNA Profiles to Distinguish Multiple Sclerosis and Neuromyelitis Optica in Peripheral Whole Blood

American Academny of Neurology

AAN 2023 Annual Meeting

Boston, MA, April 22-27, 2023

Oral presentation: RNA profiles to distinguish multiple sclerosis and neuromyelitis optica in peripheral whole blood

Authors: Wylezinski LS, Shaginurova GI, Grigorenko EV, Wohlgemuth JG, Cockerill FR, Racke MK, Spurlock CF

Specialties: Neurology

Related content

Publication
Machine Learning Analysis Using RNA Sequencing to Distinguish Neuromyelitis Optica from Multiple Sclerosis and Identify Therapeutic Candidates
Conference Presentation
Discovery of Unique RNA Profiles Associated With Plasma Neurofilament Light Chain Measurements in Relapsing-Remitting Multiple Sclerosis and Neuromyelitis Optica
Publication
Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management
Publication
Recurrent Optic Neuritis and Perineuritis Followed by an Unexpected Discovery: From the National Multiple Sclerosis Society Case Conference Proceedings
Publication
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference Proceedings

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.